Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03661892 · ClinicalTrials.gov registry record · Early Phase 1
Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets
A Early Phase 1 study, sponsored by University of Arizona.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 14
- Enrollment target
NCT03661892: Completed Early Phase 1 study, sponsored by University of Arizona.
NCT03661892 is a Early Phase 1 study that has completed, run by University of Arizona. The registered enrollment target is 14 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03661892, a Early Phase 1 study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
In patients with cancer induced bone pain, addition of Syndros will improve pain relief and decrease opioid requirement.
Primary Outcome
To evaluate change in opiate pain medication use after addition of Syndros.Hypothesis: Syndros will decrease the opiate usage by at least 20% at the end of 8wks. We will evaluate opioid pain medication use by using a drug diary and assessing the percentage change in opiate pain medication requirement at end of 8wks.
Interventions
- DRUG Syndros
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-12-19 |
| Est. Completion | 2021-04-26 |
| Phase | Early Phase 1 |
What the finished NCT03661892 record still lists
NCT03661892 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which Syndros is the first listed.
NCT03661892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03661892 about?
NCT03661892 is a clinical study titled "Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets". In patients with cancer induced bone pain, addition of Syndros will improve pain relief and decrease opioid requirement.
What is the current status of trial NCT03661892?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 14 participants. The study started on 2018-12-19. Estimated completion is 2021-04-26.
What interventions are being tested in trial NCT03661892?
The interventions under investigation include: Syndros (DRUG).
Who is sponsoring clinical trial NCT03661892?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03661892's enrollment target sits among peer trials
14 1474th of 2000 higher than 498 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy